Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation

Rhea-AI Summary

Prestige Consumer Healthcare (NYSE:PBH) has announced two important upcoming events. First, the company will release its fiscal 2025 third quarter earnings on Thursday, February 6, 2025, before market opening, followed by a conference call at 8:30 a.m. ET. Investors can join the webcast through the company's Investor Relations webpage or register for phone participation.

Additionally, PBH will participate in a fireside chat at the 27th annual ICR Conference in Orlando, FL on Tuesday, January 14th, at 11:30 a.m. ET. Both events will be accessible via webcast on the company's website, with replays available afterward.

TARRYTOWN, N.Y., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 third quarter earnings release on Thursday, February 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.

A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.

ICR Conference

The Company will also participate in a fireside chat at the 27^th annual ICR Conference in Orlando, FL on Tuesday, January 14^th, at 11:30 a.m. ET.   Media and investors can listen to a live audio webcast by visiting the Investor Relations page of the company’s website at www.prestigeconsumerhealthcare.com. A replay of the webcast will be available later that same day.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat^® and Summer’s Eve^® women's health products, BC^® and Goody's^® pain relievers, Clear Eyes^® and TheraTears^® eye care products, DenTek^® specialty oral care products, Dramamine^® motion sickness treatments, Fleet^® enemas and glycerin suppositories, Chloraseptic^® and Luden's^® sore throat treatments and drops, Compound W^® wart treatments, Little Remedies^® pediatric over-the-counter products, Boudreaux’s Butt Paste^® diaper rash ointments, Nix^® lice treatment, Debrox^® earwax remover, Gaviscon^® antacid in Canada, and Hydralyte^® rehydration products and the Fess^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com

FAQ

When will Prestige Consumer Healthcare (PBH) release its Q3 2025 earnings?

Prestige Consumer Healthcare will release its fiscal 2025 third quarter earnings on Thursday, February 6, 2025, before the market opens.

What time is PBH's Q3 2025 earnings conference call?

The earnings conference call will be held at 8:30 a.m. ET on Thursday, February 6, 2025.

When is Prestige Consumer Healthcare presenting at the ICR Conference?

PBH will participate in a fireside chat at the ICR Conference on Tuesday, January 14th, at 11:30 a.m. ET in Orlando, FL.

How can investors access PBH's Q3 2025 earnings call?

Investors can access the earnings call through a live webcast on the company's Investor Relations webpage or register for phone participation.